Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Revolution Medicines (RVMD)

$183.90 −$3.09 (−1.65%)

Day’s range
$181.00–$188.30
Volume
1.7M

RVMD price history

RVMD closed at $183.90 on Oct. 26, 2026. Over the past year, its daily close ranged from $57.99 on Oct. 27, 2025 to $221.15 on Aug. 27, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $50 to $250, not from zero.
Data table: RVMD daily closes, the past year
RVMD daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$183.90
Oct. 23, 2026$186.99
Oct. 22, 2026$187.69
Oct. 21, 2026$194.28
Oct. 20, 2026$196.55
Oct. 19, 2026$182.15
Oct. 16, 2026$177.96
Oct. 15, 2026$189.26
Oct. 14, 2026$193.52
Oct. 13, 2026$188.44
Oct. 12, 2026$193.95
Oct. 9, 2026$189.76
Oct. 8, 2026$188.12
Oct. 7, 2026$200.87
Oct. 6, 2026$199.87
Oct. 5, 2026$207.68
Oct. 2, 2026$206.64
Oct. 1, 2026$205.89
Sept. 30, 2026$205.26
Sept. 29, 2026$204.48
Sept. 28, 2026$201.74
Sept. 25, 2026$204.97
Sept. 24, 2026$199.86
Sept. 23, 2026$190.74
Sept. 22, 2026$192.86
Sept. 21, 2026$192.76
Sept. 18, 2026$190.95
Sept. 17, 2026$196.94
Sept. 16, 2026$195.92
Sept. 15, 2026$204.86
Sept. 14, 2026$205.11
Sept. 11, 2026$203.77
Sept. 10, 2026$203.35
Sept. 9, 2026$207.68
Sept. 8, 2026$207.32
Sept. 4, 2026$210.02
Sept. 3, 2026$210.87
Sept. 2, 2026$209.23
Sept. 1, 2026$209.87
Aug. 31, 2026$205.57
Aug. 28, 2026$207.88
Aug. 27, 2026$221.15
Aug. 26, 2026$215.44
Aug. 25, 2026$211.38
Aug. 24, 2026$211.58
Aug. 21, 2026$209.46
Aug. 20, 2026$211.74
Aug. 19, 2026$214.66
Aug. 18, 2026$216.00
Aug. 17, 2026$212.00
Aug. 14, 2026$203.71
Aug. 13, 2026$202.00
Aug. 12, 2026$205.26
Aug. 11, 2026$205.55
Aug. 10, 2026$206.97
Aug. 7, 2026$205.15
Aug. 6, 2026$197.81
Aug. 5, 2026$197.30
Aug. 4, 2026$193.46
Aug. 3, 2026$182.45
July 31, 2026$187.53
July 30, 2026$192.17
July 29, 2026$180.92
July 28, 2026$183.86
July 27, 2026$188.07
July 24, 2026$189.23
July 23, 2026$188.75
July 22, 2026$183.03
July 21, 2026$183.29
July 20, 2026$180.39
July 17, 2026$186.16
July 16, 2026$179.18
July 15, 2026$184.44
July 14, 2026$184.97
July 13, 2026$183.95
July 10, 2026$186.88
July 9, 2026$191.13
July 8, 2026$189.77
July 7, 2026$190.46
July 6, 2026$189.99
July 2, 2026$189.24
July 1, 2026$187.51
June 30, 2026$187.28
June 29, 2026$192.62
June 26, 2026$182.08
June 25, 2026$178.17
June 24, 2026$169.77
June 23, 2026$169.51
June 22, 2026$165.81
June 18, 2026$162.99
June 17, 2026$157.77
June 16, 2026$156.58
June 15, 2026$160.06
June 12, 2026$153.87
June 11, 2026$149.23
June 10, 2026$144.19
June 9, 2026$149.55
June 8, 2026$148.49
June 5, 2026$149.23
June 4, 2026$155.69
June 3, 2026$155.99
June 2, 2026$151.31
June 1, 2026$163.68
May 29, 2026$157.48
May 28, 2026$154.63
May 27, 2026$153.00
May 26, 2026$154.89
May 22, 2026$151.56
May 21, 2026$153.73
May 20, 2026$150.33
May 19, 2026$147.30
May 18, 2026$144.37
May 15, 2026$145.66
May 14, 2026$149.47
May 13, 2026$149.94
May 12, 2026$145.72
May 11, 2026$144.15
May 8, 2026$141.81
May 7, 2026$142.51
May 6, 2026$151.07
May 5, 2026$147.21
May 4, 2026$147.90
May 1, 2026$139.48
April 30, 2026$144.12
April 29, 2026$140.55
April 28, 2026$144.83
April 27, 2026$131.67
April 24, 2026$135.30
April 23, 2026$134.48
April 22, 2026$141.50
April 21, 2026$148.90
April 20, 2026$146.23
April 17, 2026$148.63
April 16, 2026$149.27
April 15, 2026$152.54
April 14, 2026$147.01
April 13, 2026$136.30
April 10, 2026$96.43
April 9, 2026$96.22
April 8, 2026$96.75
April 7, 2026$96.29
April 6, 2026$95.36
April 2, 2026$99.12
April 1, 2026$98.64
March 31, 2026$97.25
March 30, 2026$92.71
March 27, 2026$92.51
March 26, 2026$93.21
March 25, 2026$94.29
March 24, 2026$95.52
March 23, 2026$96.63
March 20, 2026$95.78
March 19, 2026$99.29
March 18, 2026$98.11
March 17, 2026$99.13
March 16, 2026$99.00
March 13, 2026$94.86
March 12, 2026$95.07
March 11, 2026$99.59
March 10, 2026$98.86
March 9, 2026$99.79
March 6, 2026$98.40
March 5, 2026$99.64
March 4, 2026$101.19
March 3, 2026$100.49
March 2, 2026$101.62
Feb. 27, 2026$102.02
Feb. 26, 2026$102.15
Feb. 25, 2026$103.24
Feb. 24, 2026$104.83
Feb. 23, 2026$103.69
Feb. 20, 2026$101.83
Feb. 19, 2026$102.74
Feb. 18, 2026$99.79
Feb. 17, 2026$100.61
Feb. 13, 2026$96.31
Feb. 12, 2026$97.33
Feb. 11, 2026$97.99
Feb. 10, 2026$95.98
Feb. 9, 2026$96.74
Feb. 6, 2026$97.49
Feb. 5, 2026$96.15
Feb. 4, 2026$96.51
Feb. 3, 2026$95.97
Feb. 2, 2026$97.16
Jan. 30, 2026$96.95
Jan. 29, 2026$98.20
Jan. 28, 2026$97.33
Jan. 27, 2026$99.82
Jan. 26, 2026$97.78
Jan. 23, 2026$117.63
Jan. 22, 2026$118.81
Jan. 21, 2026$117.53
Jan. 20, 2026$116.22
Jan. 16, 2026$120.28
Jan. 15, 2026$123.27
Jan. 14, 2026$121.22
Jan. 13, 2026$119.95
Jan. 12, 2026$117.17
Jan. 9, 2026$118.64
Jan. 8, 2026$107.39
Jan. 7, 2026$102.71
Jan. 6, 2026$79.85
Jan. 5, 2026$78.33
Jan. 2, 2026$79.02
Dec. 31, 2025$79.65
Dec. 30, 2025$79.67
Dec. 29, 2025$80.52
Dec. 26, 2025$80.75
Dec. 24, 2025$81.19
Dec. 23, 2025$80.27
Dec. 22, 2025$80.58
Dec. 19, 2025$78.78
Dec. 18, 2025$75.96
Dec. 17, 2025$76.74
Dec. 16, 2025$77.56
Dec. 15, 2025$79.00
Dec. 12, 2025$78.92
Dec. 11, 2025$78.51
Dec. 10, 2025$77.88
Dec. 9, 2025$77.81
Dec. 8, 2025$80.06
Dec. 5, 2025$79.64
Dec. 4, 2025$78.48
Dec. 3, 2025$77.69
Dec. 2, 2025$75.31
Dec. 1, 2025$75.80
Nov. 28, 2025$77.76
Nov. 26, 2025$77.58
Nov. 25, 2025$76.32
Nov. 24, 2025$73.66
Nov. 21, 2025$70.87
Nov. 20, 2025$69.88
Nov. 19, 2025$70.53
Nov. 18, 2025$70.58
Nov. 17, 2025$69.14
Nov. 14, 2025$67.75
Nov. 13, 2025$64.38
Nov. 12, 2025$65.83
Nov. 11, 2025$64.08
Nov. 10, 2025$62.73
Nov. 7, 2025$61.01
Nov. 6, 2025$61.38
Nov. 5, 2025$59.34
Nov. 4, 2025$58.57
Nov. 3, 2025$59.33
Oct. 31, 2025$58.84
Oct. 30, 2025$58.87
Oct. 29, 2025$58.02
Oct. 28, 2025$58.17
Oct. 27, 2025$57.99

Key figures

52-week range
$54.48–$221.15Low Oct. 24, 2025; high Aug. 27, 2026
Average daily volume
2.0MPast 3 months
Market value
$39.42B
Dividend yield
—
From 52-week high
−16.84%

Price change

1 month
−10.28%
3 months
−2.82%
Year to date
+130.89%
1 year
+237.56%

$1,000 a year ago

$1,000 put into RVMD at the close on Oct. 24, 2025 would be worth $3,376.

Price only, dividends not included.

What Wall Street says about RVMD

In the past 90 days, Wall Street firms published 28 rating or price-target actions on RVMD: 4 new ratings, 2 reiterated ratings and 22 raised price targets.

Rating and price-target actions on RVMD, past 90 days
ActionRating
TD CowenReiteratesBuy$250
Truist SecuritiesRaises targetBuy$240 to $241
William BlairInitiates coverageOutperform—
NeedhamReiteratesBuy$275
RBC CapitalRaises targetOutperform$259 to $260
RBC CapitalRaises targetOutperform$251 to $259
Truist SecuritiesRaises targetBuy$239 to $240
Brookline CapitalInitiates coverageBuy$318
Goldman SachsReinstates coverageBuy$267
B of A SecuritiesRaises targetBuy$225 to $265
Morgan StanleyInitiates coverageOverweight$255
StifelRaises targetBuy$215 to $230
NeedhamRaises targetBuy$240 to $275
GuggenheimRaises targetBuy$240 to $275
UBSRaises targetBuy$220 to $265
Evercore ISI GroupRaises targetOutperform$230 to $320
HC Wainwright & Co.Raises targetBuy$195 to $280
OppenheimerRaises targetOutperform$230 to $260
RBC CapitalRaises targetOutperform$203 to $251
Truist SecuritiesRaises targetBuy$231 to $239
WedbushRaises targetOutperform$201 to $225
BernsteinRaises targetMarket perform$151 to $179
Truist SecuritiesRaises targetBuy$210 to $231
Evercore ISI GroupRaises targetOutperform$220 to $230
GuggenheimRaises targetBuy$235 to $240
NeedhamRaises targetBuy$236 to $240
RBC CapitalRaises targetOutperform$182 to $203
WedbushRaises targetOutperform$192.10 to $201

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Revolution Medicines, Inc. Common Stock

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Headquarters
Redwood City, Calif.
Employees
883
Listed
Feb. 13, 2020
Sector
Health care
Industry
Biological products, (no diagnostic substances)

revmed.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about RVMD is on the site yet.

  • AMGNAmgen Inc
  • GILDGilead Sciences Inc
  • MRNAModerna, Inc. Common Stock
  • BIIBBiogen Inc. Common Stock
  • EXELExelixis Inc
  • HALOHalozyme Therapeutics, Inc.